Displaying 37 - 48 of 85
Metabolism, Alcohol & Toxicity

Setting the scene: from NASH to MASH and beyond

Webcasts
View
Metabolism, Alcohol & Toxicity

Navigating MASH in 2024 and beyond: audience Q&A

Webcasts
View
Metabolism, Alcohol & Toxicity

Breaking new ground: evidence-based care pathways and advances in clinical development

Webcasts
View
Metabolism, Alcohol & Toxicity

State-of-the-art: screening and diagnostic tools in MASH

Webcasts
View
Metabolism, Alcohol & Toxicity

Welcome and Introduction

Webcasts
View
Metabolism, Alcohol & Toxicity

Metabolic and toxic liver damage in focus - MANPOWER's Latest Breakthroughs Revealed.

Webcasts
View
Metabolism, Alcohol & Toxicity

MAFLD in Focus: Unveiling Insights from RELIEF Study - Insight from APASL 2024

Webcasts
View
Metabolism, Alcohol & Toxicity

Sanofi: Reducing the burden of liver disease - new evidence revealed (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Q&A

Webcasts
View
Metabolism, Alcohol & Toxicity

Metabolic Comorbidities Unmasked -  Redefining MASLD/MASH Impact

Webcasts
View
Metabolism, Alcohol & Toxicity

Shedding light on genomic, metabolic, and phenotypic effects of essential phospholipids on HepaRG

Webcasts
View
Immune-Mediated and Cholestatic Diseases

Chair’s Welcome and Introduction

Webcasts
View
Displaying 37 - 48 of 85